| UniProt ID | DAP1_HUMAN | |
|---|---|---|
| UniProt AC | P51397 | |
| Protein Name | Death-associated protein 1 | |
| Gene Name | DAP | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 102 | |
| Subcellular Localization | ||
| Protein Description | Negative regulator of autophagy. Involved in mediating interferon-gamma-induced cell death.. | |
| Protein Sequence | MSSPPEGKLETKAGHPPAVKAGGMRIVQKHPHTGDTKEEKDKDDQEWESPSPPKPTVFISGVIARGDKDFPPAAAQVAHQKPHASMDKHPSPRTQHIQQPRK | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MSSPPEGKL ------CCCCCCCCC | 52.10 | 23401153 | |
| 2 | Acetylation | ------MSSPPEGKL ------CCCCCCCCC | 52.10 | 20068231 | |
| 3 | Phosphorylation | -----MSSPPEGKLE -----CCCCCCCCCC | 43.08 | 23401153 | |
| 8 | Acetylation | MSSPPEGKLETKAGH CCCCCCCCCCCCCCC | 41.30 | 25953088 | |
| 8 | Ubiquitination | MSSPPEGKLETKAGH CCCCCCCCCCCCCCC | 41.30 | - | |
| 11 | Phosphorylation | PPEGKLETKAGHPPA CCCCCCCCCCCCCCC | 36.31 | 29396449 | |
| 12 | Ubiquitination | PEGKLETKAGHPPAV CCCCCCCCCCCCCCE | 42.89 | - | |
| 20 | Acetylation | AGHPPAVKAGGMRIV CCCCCCEEECCEEEE | 43.34 | 26822725 | |
| 29 | Acetylation | GGMRIVQKHPHTGDT CCEEEEECCCCCCCC | 48.48 | 26822725 | |
| 29 | Ubiquitination | GGMRIVQKHPHTGDT CCEEEEECCCCCCCC | 48.48 | 21906983 | |
| 33 | Phosphorylation | IVQKHPHTGDTKEEK EEECCCCCCCCCCCC | 41.00 | 26074081 | |
| 36 | Phosphorylation | KHPHTGDTKEEKDKD CCCCCCCCCCCCCCC | 41.52 | 26091039 | |
| 49 | Phosphorylation | KDDQEWESPSPPKPT CCCCCCCCCCCCCCE | 31.58 | 22167270 | |
| 51 | Phosphorylation | DQEWESPSPPKPTVF CCCCCCCCCCCCEEE | 64.21 | 22167270 | |
| 56 | Phosphorylation | SPSPPKPTVFISGVI CCCCCCCEEEEEEEE | 33.89 | 30175587 | |
| 60 | Phosphorylation | PKPTVFISGVIARGD CCCEEEEEEEEECCC | 18.62 | 22115753 | |
| 68 | Acetylation | GVIARGDKDFPPAAA EEEECCCCCCCHHHH | 65.18 | 23954790 | |
| 81 | Acetylation | AAQVAHQKPHASMDK HHHHHHCCCCCCCCC | 28.98 | 23954790 | |
| 85 | Phosphorylation | AHQKPHASMDKHPSP HHCCCCCCCCCCCCC | 25.20 | 23927012 | |
| 91 | Phosphorylation | ASMDKHPSPRTQHIQ CCCCCCCCCCHHHCC | 27.08 | 23927012 | |
| 93 | Methylation | MDKHPSPRTQHIQQP CCCCCCCCHHHCCCC | 51.89 | - | |
| 94 | Phosphorylation | DKHPSPRTQHIQQPR CCCCCCCHHHCCCCC | 28.08 | 29514088 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of DAP1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DAP1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| SETB1_HUMAN | SETDB1 | physical | 16169070 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Beyond linker histones and high mobility group proteins: globalprofiling of perchloric acid soluble proteins."; Zougman A., Wisniewski J.R.; J. Proteome Res. 5:925-934(2006). Cited for: PROTEIN SEQUENCE OF 2-8 AND 41-65, ACETYLATION AT SER-2,PHOSPHORYLATION AT SER-3; SER-49 AND SER-51, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "DAP1, a novel substrate of mTOR, negatively regulates autophagy."; Koren I., Reem E., Kimchi A.; Curr. Biol. 20:1093-1098(2010). Cited for: FUNCTION IN AUTOPHAGY, AND PHOSPHORYLATION AT SER-3 AND SER-51 BYMTOR. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-49; SER-51 AND SER-91,AND MASS SPECTROMETRY. | |
| "Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-91, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-51, AND MASSSPECTROMETRY. | |
| "Beyond linker histones and high mobility group proteins: globalprofiling of perchloric acid soluble proteins."; Zougman A., Wisniewski J.R.; J. Proteome Res. 5:925-934(2006). Cited for: PROTEIN SEQUENCE OF 2-8 AND 41-65, ACETYLATION AT SER-2,PHOSPHORYLATION AT SER-3; SER-49 AND SER-51, AND MASS SPECTROMETRY. | |